Summary
Distributed Denial of Service (DDoS) attacks are a serious threat to many businesses which rely on constant availability of their network services. Some of the most vicious DDoS attacks occur at the application-layer as these are very hard to defend against because of the many different ways in which hackers may strike. In attack prevention, it is crucial to automatically distinguish between legitimate and malicious traffic. Our Ammune solution outperforms all other state-of-the-art competitors by using highly adaptive artificial intelligence algorithms. It is able to detect previously unknown attack types in real time, with very low rates of errors, for low bandwidth to very high bandwidth attacks.
The DDoS defence solution market is estimated at €1.4Bn currently growing at a CAGR of 23% and expected to grow faster in the wake of the increasing attacks. Ammune has already been successfully trialled at two sites (Israeli government ISP and InterUniversity Computation Center) where it detected advanced DDoS attacks which were not found by any of the existing defence systems deployed at the sites. Following these early successes, L7Defense is in discussion with a number of beta customers in Europe, USA and Australia for initial pilots (see section 4) and has been invited by the Luxembourg government to deploy Ammune technology in their data centers, as part of the effort of improving its cyberdefence infrastructure. This led the Luxembourg Innovation agency to select us in their Fit4Start programme to support the development, pilot sales and commercialization.
L7Defense currently has and has raised 850k Euros from private investors. The phase 1 project will confirm the market interest in 3 specific customer segments by interviewing 25 companies and recruiting 5 early adopters for phase 2 trials.
The DDoS defence solution market is estimated at €1.4Bn currently growing at a CAGR of 23% and expected to grow faster in the wake of the increasing attacks. Ammune has already been successfully trialled at two sites (Israeli government ISP and InterUniversity Computation Center) where it detected advanced DDoS attacks which were not found by any of the existing defence systems deployed at the sites. Following these early successes, L7Defense is in discussion with a number of beta customers in Europe, USA and Australia for initial pilots (see section 4) and has been invited by the Luxembourg government to deploy Ammune technology in their data centers, as part of the effort of improving its cyberdefence infrastructure. This led the Luxembourg Innovation agency to select us in their Fit4Start programme to support the development, pilot sales and commercialization.
L7Defense currently has and has raised 850k Euros from private investors. The phase 1 project will confirm the market interest in 3 specific customer segments by interviewing 25 companies and recruiting 5 early adopters for phase 2 trials.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: | https://cordis.europa.eu/project/id/815564 |
Start date: | 01-08-2018 |
End date: | 31-12-2018 |
Total budget - Public funding: | 71 429,00 Euro - 50 000,00 Euro |
Cordis data
Original description
Distributed Denial of Service (DDoS) attacks are a serious threat to many businesses which rely on constant availability of their network services. Some of the most vicious DDoS attacks occur at the application-layer as these are very hard to defend against because of the many different ways in which hackers may strike. In attack prevention, it is crucial to automatically distinguish between legitimate and malicious traffic. Our Ammune solution outperforms all other state-of-the-art competitors by using highly adaptive artificial intelligence algorithms. It is able to detect previously unknown attack types in real time, with very low rates of errors, for low bandwidth to very high bandwidth attacks.The DDoS defence solution market is estimated at €1.4Bn currently growing at a CAGR of 23% and expected to grow faster in the wake of the increasing attacks. Ammune has already been successfully trialled at two sites (Israeli government ISP and InterUniversity Computation Center) where it detected advanced DDoS attacks which were not found by any of the existing defence systems deployed at the sites. Following these early successes, L7Defense is in discussion with a number of beta customers in Europe, USA and Australia for initial pilots (see section 4) and has been invited by the Luxembourg government to deploy Ammune technology in their data centers, as part of the effort of improving its cyberdefence infrastructure. This led the Luxembourg Innovation agency to select us in their Fit4Start programme to support the development, pilot sales and commercialization.
L7Defense currently has and has raised 850k Euros from private investors. The phase 1 project will confirm the market interest in 3 specific customer segments by interviewing 25 companies and recruiting 5 early adopters for phase 2 trials.
Status
CLOSEDCall topic
EIC-SMEInst-2018-2020Update Date
27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all